<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">milmed</journal-id><journal-title-group><journal-title xml:lang="ru">Военная медицина</journal-title><trans-title-group xml:lang="en"><trans-title>Military Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-5044</issn><publisher><publisher-name>Белорусский государственный медицинский университет</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">milmed-823</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ НАУЧНЫЕ ПУБЛИКАЦИИ. Лечебно-профилактические вопросы</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL SCIENTIFIC PUBLICATIONS. Medical and preventive questions</subject></subj-group></article-categories><title-group><article-title>Нтибактериальная терапия гонококковой инфекции: проблемы, вопросы выбора этиотропной терапии</article-title><trans-title-group xml:lang="en"><trans-title>Antibacterial therapy of racing infections: problems, questions of choice of etiotropic therapy</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Анискевич</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Aniskevich</surname><given-names>A. V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шиманская</surname><given-names>И. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Shimanskaya</surname><given-names>I. G.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>УО «Белорусский государственный медицинский университет»</institution><country>Belarus</country></aff><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>27</day><month>10</month><year>2026</year></pub-date><volume>0</volume><issue>2</issue><fpage>28</fpage><lpage>33</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Анискевич А.В., Шиманская И.Г., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Анискевич А.В., Шиманская И.Г.</copyright-holder><copyright-holder xml:lang="en">Aniskevich A.V., Shimanskaya I.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://milmed.ejournal.by/jour/article/view/823">https://milmed.ejournal.by/jour/article/view/823</self-uri><abstract><p>Современные лекарственные средства первого выбора для лечения гонореи должны быть широкодоступны, малотоксичны, вызывать эрадикацию гонококка при однократном применении и быстро приводить к излечению инфицированных пациентов. При выборе способа лечения гонококковой инфекции ВОЗ рекомендует проводить тест на антимикробную чувствительность, а при отсутствии такой возможности применять комбинированную терапию. Допускается применение монотерапии, однако способ лечения зависит от надежных местных данных об антимикробной чувствительности.Статья посвящена анализу методов терапии пациентов с гонококковой инфекцией, а также изучению соответствия проводимого лечения клиническим протоколам, утвержденным Министерством здравоохранения Республики Беларусь N 1020 от 29.10.2009 г., а также международным рекомендациям. Установлено, что ввиду высокой резистентности гонококка к лекарственным средствам пенициллинового, тетрациклинового ряда и макролидам использование их в качестве монотерапии нецелесообразно. Назначение комбинированной терапии (цефтриаксон + азитромицин) позволит не только снизить риск развития резистентности к цефтриаксону, но и повысить результативность лечения пациентов, не прошедших полноценного лабораторного обследования на другие ИППП.</p></abstract><trans-abstract xml:lang="en"><p>Modern drugs of first choice for the treatment of gonorrhea should be widely available, low toxicity, cause eradication of gonococcus with a single use and quickly lead to the cure of infected patients. When choosing a method of treatment for gonococcal infection, WHO recommends a test for antimicrobial sensitivity, and in the absence of such an opportunity to use combination therapy. Monotherapy is allowed, but the choice of treatment depends on reliable local data on antimicrobial sensitivity. The article presents the outcomes of studies and results of treatments of patients with gonococcal infections, as well as the compliance of ongoing outpatient treatments according to clinical protocols approved in the Republic of Belarus by order N 1020 of 10.29.2009. It has been established that, due to the high resistance of gonococcus to penicillin, tetracycline and macrolide drugs, their use as monotherapy is impractical. The appointment of combination therapy (ceftriaxone + azithromycin) will not only reduce the risk of developing resistance to ceftriaxone, but also increase the effectiveness of treatment of under-examined patients with co-infection with C. Trachomatis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>N. gonorrhoeae</kwd><kwd>гонорея</kwd><kwd>лечение</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Neisseria gonorrhoeae</kwd><kwd>Gonorrhoea</kwd><kwd>treatment</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Unemo, M. Antimicrobial Resistance Expressed by Neisseria gonorrhoeae: A Major Global Public Health Problem in the 21st Century / M. Unemo, C. del Rio, W. M. Shafer // Microbiology Spectrum. – 2016. – Vol. 10. – P. 213–237. – doi: 10.1128/microbiolspec.ei10-0009-2015</mixed-citation><mixed-citation xml:lang="en">Unemo, M. Antimicrobial Resistance Expressed by Neisseria gonorrhoeae: A Major Global Public Health Problem in the 21st Century / M. Unemo, C. del Rio, W. M. Shafer // Microbiology Spectrum. – 2016. – Vol. 10. – P. 213–237. – doi: 10.1128/microbiolspec.ei10-0009-2015</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">A systematic review and appraisal of the quality of practice guidelines for the management of Neisseria gonorrhoeaeinfections / C. Dickson [et al.] // Sexually Transmitted Infections. – 2017. – Vol. 93(7). – P. 487–492. – doi: 10.1136/sextrans-2016-052939</mixed-citation><mixed-citation xml:lang="en">A systematic review and appraisal of the quality of practice guidelines for the management of Neisseria gonorrhoeaeinfections / C. Dickson [et al.] // Sexually Transmitted Infections. – 2017. – Vol. 93(7). – P. 487–492. – doi: 10.1136/sextrans-2016-052939</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Gonorrhea: what goes around comes around / N. E. MacDonald [et al.] // Canadian Medical Association Journal. – 2011. – Vol. 183(14). – P. 1567–1567. – doi: 10.1503/cmaj.111393</mixed-citation><mixed-citation xml:lang="en">Gonorrhea: what goes around comes around / N. E. MacDonald [et al.] // Canadian Medical Association Journal. – 2011. – Vol. 183(14). – P. 1567–1567. – doi: 10.1503/cmaj.111393</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Global Action Plan to Control the Spread and Impact of Antimicrobial Resistance in Neisseria gonorrhoeae / World Health Organization. – Geneva(Switzerland), 2012. – 36 p.</mixed-citation><mixed-citation xml:lang="en">Global Action Plan to Control the Spread and Impact of Antimicrobial Resistance in Neisseria gonorrhoeae / World Health Organization. – Geneva(Switzerland), 2012. – 36 p.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Suay-García, B. Future Prospects for Neisseria gonorrhoeae Treatment / B. Suay-García, M. Pérez-Gracia // Antibiotics. – 2018. – Vol. 7(2). – P. 49. – doi: 10.3390/antibiotics7020049</mixed-citation><mixed-citation xml:lang="en">Suay-García, B. Future Prospects for Neisseria gonorrhoeae Treatment / B. Suay-García, M. Pérez-Gracia // Antibiotics. – 2018. – Vol. 7(2). – P. 49. – doi: 10.3390/antibiotics7020049</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">WHO guidelines for the treatment of Neisseria gonorrhoeae / World Health Organization. – Access mode: https://apps.who.int/iris/bitstream/handle/10665/246114/9789241549691-eng.pdf?sequence=1</mixed-citation><mixed-citation xml:lang="en">WHO guidelines for the treatment of Neisseria gonorrhoeae / World Health Organization. – Access mode: https://apps.who.int/iris/bitstream/handle/10665/246114/9789241549691-eng.pdf?sequence=1</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Australasian Sexual Health Alliance. Australian STI Management Guidelines for Use in Primary Care. 2018. – Access mode: http://www.sti.guidelines.org.au/sexually-transmissible-infections/gonorrhoea</mixed-citation><mixed-citation xml:lang="en">Australasian Sexual Health Alliance. Australian STI Management Guidelines for Use in Primary Care. 2018. – Access mode: http://www.sti.guidelines.org.au/sexually-transmissible-infections/gonorrhoea</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">The antibiotic management of gonorrhoea in Ontario, Canada following multiple changes in guidelines: an interrupted time-series analysis / C. Dickson [et al.] // Sexually Transmitted Infections. – 2017. – Vol. 93(8). – P. 561–565. – doi: 10.1136/sextrans-2017-053224</mixed-citation><mixed-citation xml:lang="en">The antibiotic management of gonorrhoea in Ontario, Canada following multiple changes in guidelines: an interrupted time-series analysis / C. Dickson [et al.] // Sexually Transmitted Infections. – 2017. – Vol. 93(8). – P. 561–565. – doi: 10.1136/sextrans-2017-053224</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Canadian guidelines on sexually transmitted infections: Gonococcal Infections Chapter / Public Health Agency of Canada. 2013. – Access mode: http://www.phac-aspc.gc.ca/std-mts/sti-its/cgsti-ldcits/assets/pdf/section-5-6-eng.pdf</mixed-citation><mixed-citation xml:lang="en">Canadian guidelines on sexually transmitted infections: Gonococcal Infections Chapter / Public Health Agency of Canada. 2013. – Access mode: http://www.phac-aspc.gc.ca/std-mts/sti-its/cgsti-ldcits/assets/pdf/section-5-6-eng.pdf</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Gonococcal Infections // Sexually transmitted diseases treatment guidelines / Centers for Disease Control and Prevention. 2015. – Access mode: http://www.cdc.gov/std/tg2015/gonorrhea.htm</mixed-citation><mixed-citation xml:lang="en">Gonococcal Infections // Sexually transmitted diseases treatment guidelines / Centers for Disease Control and Prevention. 2015. – Access mode: http://www.cdc.gov/std/tg2015/gonorrhea.htm</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">European guideline on the diagnosis and treatment of gonorrhoea in adults / C. Bignell [et al.] // International Journal of STD &amp; AIDS. – 2012. – Vol. 24(2). – P. 85–92. – Access mode: doi: 10.1177/0956462412472837</mixed-citation><mixed-citation xml:lang="en">European guideline on the diagnosis and treatment of gonorrhoea in adults / C. Bignell [et al.] // International Journal of STD &amp; AIDS. – 2012. – Vol. 24(2). – P. 85–92. – Access mode: doi: 10.1177/0956462412472837</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Дерматовенерология – 2015: Болезни кожи. Инфекции, передаваемые половым путем : федеральные клинические рекомендации. – М. : Деловой экспресс, 2016. – 5-е изд., перераб. и доп. – 768 с. – ISBN 978-5-89644-123-6</mixed-citation><mixed-citation xml:lang="en">Дерматовенерология – 2015: Болезни кожи. Инфекции, передаваемые половым путем : федеральные клинические рекомендации. – М. : Деловой экспресс, 2016. – 5-е изд., перераб. и доп. – 768 с. – ISBN 978-5-89644-123-6</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Клинический протокол диагностики и лечения пациентов с инфекциями, передаваемыми половым путем : Приложение 2 к приказу Министерства здравоохранения Республики Беларусь 29.10.2009, № 1020. – Режим доступа: https://medznate.ru/docs/index-21995.html</mixed-citation><mixed-citation xml:lang="en">Клинический протокол диагностики и лечения пациентов с инфекциями, передаваемыми половым путем : Приложение 2 к приказу Министерства здравоохранения Республики Беларусь 29.10.2009, № 1020. – Режим доступа: https://medznate.ru/docs/index-21995.html</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
